Transcription profiling of gene expression in drug discovery and development: The NCI experience

European Journal of Cancer

Volumn 40, Issue 17 SPEC. ISS., 2004, Pages 2544-2549

  Sausville, Edward A ^a   Holbeck, Susan L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Drug candidates; Gene expression; Microarray; Targets; Technologies; Transcript profiling

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; FLUOROURACIL;

CANCER CELL CULTURE; CANCER GENETICS; CANCER PATIENT; CORRELATION ANALYSIS; CYTOTOXICITY; DNA MICROARRAY; DRUG ACTIVITY; DRUG APPROVAL; DRUG EFFECT; DRUG EXPOSURE; DRUG INFORMATION; DRUG MECHANISM; DRUG RESPONSE; DRUG SCREENING; DRUG SENSITIVITY; DRUG TARGETING; DRUG TRANSPORT; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; MEDICAL TECHNOLOGY; MOLECULAR BIOLOGY; MOLECULAR CLONING; MOLECULE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; QUALITY CONTROL; REVIEW; TUMOR; TUMOR CELL;

EID: 8444227084     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.08.006     Document Type: Article

References (26)

1. A.A. Alizadeh, M.B. Eisen, R.E. Davis, C. Ma, I.S. Lossos, and A. Rosenwald Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Nature 403 6769 2000 503 511
2. R.E. Davis, K.D. Brown, U. Siebenlist, and L.M. Staudt Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells J Exp Med 194 12 2001 1861 1874
3. T. Sorlie, C.M. Perou, R. Tibshirani, T. Aas, S. Geisler, and H. Johnsen Gene expression patterns of breast carcinomas distinguish tumour subclasses with clinical implications Proc Natl Acad Sci USA 98 19 2001 10869 10874
4. D.G. Beer, S.L. Kardia, C.C. Huang, T.J. Giordano, A.M. Levin, and D.E. Misek Gene-expression profiles predict survival of patients with lung adenocarcinoma Nat Med 8 8 2002 816 824
5. M.A. Shipp, K.N. Ross, P. Tamayo, A.P. Weng, J.L. Kutok, and R.C. Aguiar Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning Nat Med 8 1 2002 68 74
6. M.J. van de Vijver, Y.D. He, L.J. van't Veer, H. Dai, A.A. Hart, and D.W. Voskuil A gene-expression signature as a predictor of survival in breast cancer New Engl J Med 347 25 2002 1999 2009
7. N.S. Gray, L. Wodicka, A.M. Thunnissen, T.C. Norman, S. Kwon, and F.H. Espinoza Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors Science 281 5376 1998 533 538
8. M.J. Marton, J.L. DeRisi, H.A. Bennett, V.R. Iyer, M.R. Meyer, and C.J. Roberts Drug target validation and identification of secondary drug target effects using DNA microarrays Nat Med 4 11 1998 1293 1301
9. S.L. Holbeck Update on NCI in vitro drug screen utilities Eur J Cancer 40 6 2004 785 793
10. D.A. Scudiero, R.H. Shoemaker, K.D. Paull, A. Monks, S. Tierney, and T.H. Nofziger Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumour cell lines Cancer Res 48 17 1988 4827 4833
11. K.D. Paull, R.H. Shoemaker, L. Hodes, A. Monks, D.A. Scudiero, and L. Rubinstein Display and analysis of patterns of differential activity of drugs against human tumour cell lines: development of mean graph and COMPARE algorithm J Natl Cancer I 81 14 1989 1088 1092
12. W.W. van Osdol, T.G. Myers, K.D. Paull, K.W. Kohn, and J.N. Weinstein Use of the Kohonen self-organizing map to study the mechanisms of action of chemotherapeutic agents J Natl Cancer I 86 24 1994 1853 1859
13. J.N. Weinstein, K.W. Kohn, M.R. Grever, V.N. Viswanadhan, L.V. Rubinstein, and A.P. Monks Neural computing in cancer drug development: predicting mechanism of action Science 258 5081 1992 447 451
14. L. Li, H.K. Wang, S.C. Kuo, T.S. Wu, A. Mauger, and C.M. Lin Antitumour agents. 155. Synthesis and biological evaluation of 3′,6,7-substituted 2-phenyl-4-quinolones as antimicrotubule agents J Med Chem 37 20 1994 3400 3407
15. K. Chen, S.C. Kuo, M.C. Hsieh, A. Mauger, C.M. Lin, and E. Hamel Antitumour agents.174. 2′,3′,4′,5,6,7-Substituted 2-phenyl-1,8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization J Med Chem 40 14 1997 2266 2275
16. J. Adams, V.J. Palombella, E.A. Sausville, J. Johnson, A. Destree, and D.D. Lazarus Proteasome inhibitors: a novel class of potent and effective antitumour agents Cancer Res 59 11 1999 2615 2622
17. S.L. Holbeck, and E.A. Sausville The proteasome and the COMPARE algorithm J. Adams Proteasome Inhibitors in Cancer Therapy 2004 Humana Press
18. J.S. Lee, K. Paull, M. Alvarez, C. Hose, A. Monks, and M. Grever Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen Mol Pharmacol 46 4 1994 627 638
19. D.T. Ross, U. Scherf, M.B. Eisen, C.M. Perou, C. Rees, and P. Spellman Systematic variation in gene expression patterns in human cancer cell lines Nat Genet 24 3 2000 227 235
20. U. Scherf, D.T. Ross, M. Waltham, L.H. Smith, J.K. Lee, and L. Tanabe A gene expression database for the molecular pharmacology of cancer Nat Genet 24 3 2000 236 244
21. C.H. Kim, J.H. Kim, S.J. Moon, C.Y. Hsu, J.T. Seo, and Y.S. Ahn Biphasic effects of dithiocarbamates on the activity of nuclear factor-kappaB Eur J Pharmacol 392 3 2000 133 136
22. K. Wosikowski, D. Schuurhuis, K. Johnson, K.D. Paull, T.G. Myers, and J.N. Weinstein Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns J Natl Cancer I 89 20 1997 1505 1515
23. R.A. Dick, X. Yu, and T.W. Kensler NADPH alkenal/one oxidoreductase activity determines sensitivity of cancer cells to the chemotherapeutic alkylating agent irofulven Clin Cancer Res 10 4 2004 1492 1499
24. A. Algeciras-Schimnich, E.M. Pietras, B.C. Barnhart, P. Legembre, S. Vijayan, and S.L. Holbeck Two CD95 tumour classes with different sensitivities to antitumour drugs Proc Natl Acad Sci USA 100 20 2003 11445 11450
25. Y. Huang, P. Anderle, K.J. Bussey, C. Barbacioru, U. Shankavaram, and Z. Dai Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance Cancer Res 64 12 2004 4294 4301
26. R.K. Koenekoop The gene for Stargardt disease, ABCA4, is a major retinal gene: a mini-review Ophthalmic Genet 24 2 2003 75 80